Tweet
Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing" – This case study shows how scientists are streamlining the process of analyses of DNA sequence information
Download link
Download link
-
-
Thanks for sharing it.Worth reading
Accelrys also has an NGS suite. is it CLIA-certified and CAP-accredited -
Share "Building Novel Applications with Pipeline Pilot"
Hi there,
If you have downloaded this case study, could you please share with me. When I went to download it was already unavailable. That would be a great help. My email address is: [email protected]
Thanks,
SmritiComment
-
Next Generation Sequencing - Download link working
Hi Smriti,
Above given Download link is working. If not you can copy paste the link which given now
Comment
-
Iadin: Both the links dont work. What should we do?Comment
-
Iadin,
The links are not available. Would you mind sharing this case study with us?
It'll be grateful.
Thank you.
lzsphComment
-
Here is what I believe to be the the case study...it's pretty easy to google for the title and add "filetype : pdf" after the query.Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment